EXSTOBIO
LIVE

Serial Number

97525470

Owner

EXSTOBIO, INC.

Attorney

Dustin R. Marlan TMCP-UNC

First Use Date

May 23, 2024

Filing Date

Jul 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXSTOBIO Trademark

Serial Number: 97525470 • Registration: 7566110

EXSTOBIO is a trademark filed by EXSTOBIO, INC. on July 29, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

EXSTOBIO, INC.

306 W Franklin St., Suite F
Chapel Hill, NC 27516

Entity Type: 03

Trademark Details

Filing Date

July 29, 2022

Registration Date

November 12, 2024

First Use Anywhere

May 23, 2024

First Use in Commerce

May 23, 2024

Published for Opposition

October 31, 2023

Goods & Services

Downloadable computer software for providing counseling and digital therapeutics that utilize digital health technologies to treat and manage medical or psychological conditions; Downloadable computer application software, namely, software for processing electronic health records; Downloadable computer application software, namely, software for integrating risk evaluation information, mitigation strategies, and digital therapeutics into electronic health records; Downloadable software in the fields of healthcare, medicine and wellness for use in providing patient communication, care coordination and care management, chronic disease management, and engagement between health care providers and patients; Downloadable mobile application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Computer software, namely, downloadable software and mobile application software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals and to provide healthcare counseling and social support services to patients; Downloadable computer software, namely, downloadable software and mobile application software for connecting to, with and through smart devices and smart appliances, for the purposes of collecting data and health information for patient monitoring and communications purposes from and through such smart devices and smart appliances

Patient and family health care coordination services for use in case management, namely, providing health care advisory and management services for coordinating legal, medical, physical, social, personal care and psychological services

Medical services; Medical clinical services; Health counseling; Health care and wellness services, namely, medication tracking, patient education, and patient-centric health coaching and counseling; Pharmaceutical advice; Telemedicine services; Medical services, namely, providing medical advice in the nature of medicinal cannabidiol (CBD) recommendations and other product recommendations for medical treatment purposes and related ongoing medical care to patients; health care services, namely, providing remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Providing medical information in the field of therapeutic botanical substances; Providing health information in the field of cannabidiols, and regarding indications and effects of particular cannabis strains; Medical consultation services, namely, assessing patients for eligibility requirements for the use of cannabidiols; Providing medical testing of fitness for diagnostic purposes and medical consultations to individuals to help them make health, wellness, and nutritional changes to improve health

Medical research; Scientific research; Science and Technology Services, namely, technical consultation and scientific research in the field of cannabinoid-based medicines and pharmaceuticals; Development of precision cannabinoid therapeutics through digital therapeutics, medical research, scientific research, and expert consultation; Biological research; Compiling data for research purposes in the field of medical science and medical consultancy; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements for pain treatments, sleep treatments, and epilepsy treatments; Research and development of technology in the field of the prescription of therapeutic exercise programs; Research in the field of pharmaceutical studies; Platform as a service (PAAS) featuring computer software platforms for the development, deployment, and operation of patient-directed software for tracking prescription use and personal medical data in the field of Digital Therapeutics and treatment support; Software as a service (SaaS) and Platform as a service (PAAS) for targeting, monitoring, intervening, and managing human health conditions, behaviors, and disease, and treatments related thereto; Providing temporary use of online non-downloadable computer software for counseling and providing digital therapeutics that utilize digital and online health technologies to treat and manage medical or psychological conditions; Software as a service (SaaS) services featuring software for creating, accessing and editing electronic health records; Providing temporary use of non-downloadable computer application software, namely, software for integrating risk evaluation data, mitigation strategies, and digital therapeutics data into electronic health records; Providing interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing, namely, disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Software as a service (SAAS) services featuring software for integrating and analyzing patient health data for predictive analysis of health risks and health events; Software as a service (SAAS) featuring software in the fields of healthcare, medicine and wellness for the purpose of providing an integrated health information management system using machine learning and artificial intelligence, namely, software for providing patients and health care providers access to patient information and data, and for providing patients access to personalized information relevant to patient health and wellbeing; Providing temporary use of online non- downloadable interactive web-based software application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Software as a service (SaaS) services featuring non-downloadable software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals, and to provide healthcare counseling and social support services to patients; Providing a website featuring medical research information related to cannabidiols

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 8, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 8, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 20, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 20, 2024 AITU
USE AMENDMENT FILED
Jun 25, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 25, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2023 NOAM
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 30, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 30, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 30, 2023 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2023 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 20, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 20, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2023 REAP
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2023 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 11, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 11, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 11, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 11, 2023 REAP
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 6, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 10, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2022 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 29, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2022 REAP
ASSIGNED TO EXAMINER
Aug 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2022 NWOS
NEW APPLICATION ENTERED
Aug 2, 2022 NWAP